Lilienthalstraße 3a
Schönefeld 12529
Germany
49 30 897 30 86 70
https://www.haemato.ag
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 76
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Patrick Brenske | MD & Member of Management Board | N/A | N/A | N/A |
Mr. Attila Strauss | MD & Member of Management Board | N/A | N/A | 1985 |
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
HAEMATO AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.